First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro

Debora Wernitznig (Corresponding author), Konstantinos Kiakos, Giorgia Del Favero, Nathalie Harrer, Herwig Machat, Annika Osswald, Michael A. Jakupec, Andreas Wernitznig, Wolfgang Sommergruber, Bernhard K. Keppler

Publications: Contribution to journalArticlePeer Reviewed

Fingerprint

Dive into the research topics of 'First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro'. Together they form a unique fingerprint.

Chemistry

Pharmacology, Toxicology and Pharmaceutical Science